Please Note: This trial is no longer enrolling new participants
A Phase 1b/2 Open-label Study to Assess the Safety and Efficacy of ASP546C in Participants with CLDN18.2-expressing Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma, Pancreatic Adenocarcinoma or Other Solid Tumor Types
| Protocol No. | CTO-546C-CL-0201 | Scope | National |
|---|---|---|---|
| Principal Investigator | Shadia Jalal | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase I |
